Video Experimental Relacionado
Updated: Feb 9, 2026

In Ovo Electroporations of HH Stage 10 Chicken Embryos
Published on: November 1, 2007
Producción de proteínas farmacéuticas por pollos transgénicos: varios puntos de vista hacia la siguiente etapa
Ken-Ichi Nishijima1, Yuya Okuzaki1
1Department of Animal Sciences, Graduate School of Bioagricultural Sciences, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan; Avian Bioscience Research Center, Graduate School of Bioagricultural Sciences, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan.
Los pollos transgénicos ofrecen un sistema "biorreactor animal" rentable para la producción farmacéutica. La optimización de la glicosilación y la agilización de la modificación genética son clave para avanzar en esta tecnología para la fabricación de proteínas recombinantes.
Videos de Conceptos Relacionados
Transgenic Organisms
Pharmaceutical Equivalents
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Transgenic Plants
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
Stages of Infection
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

